India’s Mankind Pharma tops Q2 profit view on higher demand for chronic drugs
India’s Mankind Pharma reported a better-than-expected second-quarter profit on Tuesday, driven by strong demand for its drugs to treat long-term illnesses, such as diabetes and cardiovascular diseases.